Dynamic Population Model

Dynamic population models quantitatively characterise disease progression and treatment effects within heterogeneous patient populations incorporating individual variability and temporal changes. Ordinary differential equation models describe pathophysiological processes generating disease manifestations. Pharmacokinetic-pharmacodynamic integration quantitates drug exposure-response relationships. Bayesian hierarchical structures account for population heterogeneity and individual patient deviations.

Clinical trial applications employ population modelling predicting patient-specific outcomes informing individualised dosing. Dose-response relationships characterise efficacy-toxicity trade-offs supporting dose selection. Disease progression models forecast untreated disease natural history providing control comparisons. Biomarker-driven population models identify patient subgroups with differential treatment response. Regulatory submissions increasingly incorporate population modelling demonstrating dose rationale and labelling recommendations. Emerging real-world data integration enhances model predictions with clinical practice information.